August 24, 2017 3:54 AM ET


Company Overview of Idenix Pharmaceuticals, Inc.

Key Executives for Idenix Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
There is no Key Executives data available.

Idenix Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Brucy Polsky M.D. 18 RelationshipsSt. Luke's-Roosevelt Hospital Center--
Robert L. Murphy M.D. 98 RelationshipsKoronis Pharma, Inc.--
Joep Lange M.D., Ph.D. 46 RelationshipsVIRxSYS Corporation--
Geoffrey Duscheiko M.D. 18 RelationshipsIdenix Pharmaceuticals, Inc.--
Stefano Vella M.D. 18 RelationshipsIdenix Pharmaceuticals, Inc.--
View All Board Members

Idenix Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D.Geoffrey Duscheiko18 Relationships19 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Idenix Pharmaceuticals, Inc. CEO Compensation
Industry Average


PCI Biotech Appoints Hans Olivecrona as Chief Medical Officer
August 23, 2017 6:00 AM ET
CTI BioPharma Corp. Announces Resignation of Matthew Plunkett as Executive Vice President, Chief Business Officer
August 22, 2017 9:22 PM ET
TARA Biosystems, Inc. Appoints Michael P. Graziano as Chief Scientific Officer
August 22, 2017 2:00 PM ET
Celgene Corporation Announces Executive Changes
August 22, 2017 1:23 PM ET
Aldevron Names Dr. Thomas Lynch as Vice President of Sales and Client Development
August 22, 2017 1:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Idenix Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at